Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Prostate cancer diagnosis: Efficacy of a simple electromagnetic MRI-TRUS fusion method to target biopsies.

Jelidi A, Ohana M, Labani A, Alemann G, Lang H, Roy C.

Eur J Radiol. 2017 Jan;86:127-134. doi: 10.1016/j.ejrad.2016.11.016. Epub 2016 Nov 9.

PMID:
28027738
2.

[Real-time MRI/US fusion-guided biopsy in biopsy-naïve and pre-biopsied patients with suspicion for prostate cancer].

Maxeiner A, Stephan C, Fischer T, Durmus T, Kilic E, Asbach P, Haas M, Günzel K, Neymeyer J, Miller K, Cash H.

Aktuelle Urol. 2015 Jan;46(1):34-8. doi: 10.1055/s-0034-1395563. Epub 2014 Dec 17. German.

PMID:
25519051
3.

Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.

Zhang Q, Wang W, Zhang B, Shi J, Fu Y, Li D, Guo S, Zhang S, Huang H, Jiang X, Zhou W, Guo H.

Int Urol Nephrol. 2017 Mar;49(3):439-448. doi: 10.1007/s11255-016-1484-8. Epub 2016 Dec 22.

PMID:
28005230
4.

[Interest using 3D ultrasound and MRI fusion biopsy for prostate cancer detection].

Marien A, De Castro Abreu A, Gill I, Villers A, Ukimura O.

Prog Urol. 2017 Sep;27(10):521-528. doi: 10.1016/j.purol.2017.05.013. Epub 2017 Jun 17. French.

PMID:
28629785
5.

The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy.

Cash H, Maxeiner A, Stephan C, Fischer T, Durmus T, Holzmann J, Asbach P, Haas M, Hinz S, Neymeyer J, Miller K, Günzel K, Kempkensteffen C.

World J Urol. 2016 Apr;34(4):525-32. doi: 10.1007/s00345-015-1671-8. Epub 2015 Aug 21.

PMID:
26293117
6.

Early experience with multiparametric magnetic resonance imaging-targeted biopsies under visual transrectal ultrasound guidance in patients suspicious for prostate cancer undergoing repeated biopsy.

Boesen L, Noergaard N, Chabanova E, Logager V, Balslev I, Mikines K, Thomsen HS.

Scand J Urol. 2015 Feb;49(1):25-34. doi: 10.3109/21681805.2014.925497. Epub 2014 Jun 12.

PMID:
24922550
7.

A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy.

Baco E, Rud E, Eri LM, Moen G, Vlatkovic L, Svindland A, Eggesbø HB, Ukimura O.

Eur Urol. 2016 Jan;69(1):149-56. doi: 10.1016/j.eururo.2015.03.041. Epub 2015 Apr 7.

8.

Primary magnetic resonance imaging/ultrasonography fusion-guided biopsy of the prostate.

Maxeiner A, Kittner B, Blobel C, Wiemer L, Hofbauer SL, Fischer T, Asbach P, Haas M, Penzkofer T, Fuller F, Miller K, Cash H.

BJU Int. 2018 Aug;122(2):211-218. doi: 10.1111/bju.14212. Epub 2018 Apr 17.

9.

Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.

Meng X, Rosenkrantz AB, Mendhiratta N, Fenstermaker M, Huang R, Wysock JS, Bjurlin MA, Marshall S, Deng FM, Zhou M, Melamed J, Huang WC, Lepor H, Taneja SS.

Eur Urol. 2016 Mar;69(3):512-7. doi: 10.1016/j.eururo.2015.06.005. Epub 2015 Jun 22.

10.

Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance.

Radtke JP, Kuru TH, Bonekamp D, Freitag MT, Wolf MB, Alt CD, Hatiboglu G, Boxler S, Pahernik S, Roth W, Roethke MC, Schlemmer HP, Hohenfellner M, Hadaschik BA.

Prostate Cancer Prostatic Dis. 2016 Sep;19(3):283-91. doi: 10.1038/pcan.2016.16. Epub 2016 May 17.

PMID:
27184812
11.

MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men.

Yarlagadda VK, Lai WS, Gordetsky JB, Porter KK, Nix JW, Thomas JV, Rais-Bahrami S.

Diagn Interv Radiol. 2018 May-Jun;24(3):115-120. doi: 10.5152/dir.2018.17422.

12.

Additional value of magnetic resonance-targeted biopsies to standard transrectal ultrasound-guided biopsies for detection of clinically significant prostate cancer.

von Below C, Wassberg C, Norberg M, Tolf A, Kullberg J, Ladjevardi S, Häggman M, Bill Axelson A, Ahlström H.

Scand J Urol. 2017 Apr;51(2):107-113. doi: 10.1080/21681805.2017.1281346. Epub 2017 Feb 24.

PMID:
28635568
13.

Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.

Arsov C, Rabenalt R, Blondin D, Quentin M, Hiester A, Godehardt E, Gabbert HE, Becker N, Antoch G, Albers P, Schimmöller L.

Eur Urol. 2015 Oct;68(4):713-20. doi: 10.1016/j.eururo.2015.06.008. Epub 2015 Jun 23.

PMID:
26116294
14.

Trans-rectal ultrasound visibility of prostate lesions identified by magnetic resonance imaging increases accuracy of image-fusion targeted biopsies.

Ukimura O, Marien A, Palmer S, Villers A, Aron M, de Castro Abreu AL, Leslie S, Shoji S, Matsugasumi T, Gross M, Dasgupta P, Gill IS.

World J Urol. 2015 Nov;33(11):1669-76. doi: 10.1007/s00345-015-1501-z. Epub 2015 Feb 6.

PMID:
25656687
15.

[Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy].

Kesch C, Radtke JP, Distler F, Boxler S, Klein T, Hüttenbrink C, Hees K, Roth W, Roethke M, Schlemmer HP, Hohenfellner M, Hadaschik BA.

Urologe A. 2016 Aug;55(8):1071-7. doi: 10.1007/s00120-016-0093-6. German.

PMID:
27168038
16.
17.

Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study.

Puech P, Rouvière O, Renard-Penna R, Villers A, Devos P, Colombel M, Bitker MO, Leroy X, Mège-Lechevallier F, Comperat E, Ouzzane A, Lemaitre L.

Radiology. 2013 Aug;268(2):461-9. doi: 10.1148/radiol.13121501. Epub 2013 Apr 11.

PMID:
23579051
18.

Accuracy of real-time magnetic resonance imaging-transrectal ultrasound fusion image-guided transperineal target biopsy with needle tracking with a mechanical position-encoded stepper in detecting significant prostate cancer in biopsy-naïve men.

Shoji S, Hiraiwa S, Ogawa T, Kawakami M, Nakano M, Hashida K, Sato Y, Hasebe T, Uchida T, Tajiri T.

Int J Urol. 2017 Apr;24(4):288-294. doi: 10.1111/iju.13306. Epub 2017 Feb 21.

19.

Magnetic Resonance and Ultrasound Image Fusion Supported Transperineal Prostate Biopsy Using the Ginsburg Protocol: Technique, Learning Points, and Biopsy Results.

Hansen N, Patruno G, Wadhwa K, Gaziev G, Miano R, Barrett T, Gnanapragasam V, Doble A, Warren A, Bratt O, Kastner C.

Eur Urol. 2016 Aug;70(2):332-40. doi: 10.1016/j.eururo.2016.02.064. Epub 2016 Mar 16.

PMID:
26995327
20.

Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial.

Tonttila PP, Lantto J, Pääkkö E, Piippo U, Kauppila S, Lammentausta E, Ohtonen P, Vaarala MH.

Eur Urol. 2016 Mar;69(3):419-25. doi: 10.1016/j.eururo.2015.05.024. Epub 2015 May 29.

PMID:
26033153

Supplemental Content

Support Center